Hispanolistic / Getty Images

Nurse helping patient with end stage colon cancer

What a Malignant Obstruction Is

As opposed to a bowel obstruction in an otherwise healthy adult, malignant obstructions can occur from tumors pressing on the intestines from within or from outside of the digestive tract, or from a physiological inability to move and digest the foods you eat. Further complicating factors might include:

Although it is not a common or anticipated effect, your survival rate drastically decreases if you have end-stage colon cancer and have been diagnosed with a malignant bowel obstruction. The average length of time from end-stage diagnosis to a bowel obstruction is approximately 13 months according to theNational Cancer Institute.The mean survival is short, estimated to be no more than four weeks.

Symptoms

The symptoms might be easily missed or attributed to treatments or medication. Most commonly reported symptoms of a malignant obstruction include:

The symptoms of a malignant obstruction do not typically self-resolve; they continue and progress in nature unless palliative measures are taken.

Diagnosis

X-rays of the abdomen and computed tomography (CT) scans will show the presence of an obstruction in your bowel. Paired with yourcancer diagnosis, stage, and symptoms, the diagnosis is usually unquestionable.

Treatment and Palliation of Symptoms

The primary treatment of malignant bowel obstruction isbowel surgery, but your ability to survive andrecover from this surgerymay vary greatly as your cancer progresses.If you want surgery to remove the obstruction, your healthcare provider must consider your prognosis as well as:

If you elect not to have surgery or are not well enough for surgical intervention, your healthcare provider has other options to help increase your comfort and decrease the severity of your symptoms. A nasogastric tube—a thin, straw sized and flexible tube—can be inserted into your nose to your stomach.

A machine that provides gentle suction can be intermittently connected to remove excess acids and stomach content to decrease nausea and vomiting. Your healthcare provider can also prescribe medications to help relieve the colicky pain and cramping in your abdomen, as well as medications to help relieve nausea.

A palliative stent can also be placed endoscopically to hold the colon open, so feces can pass normally.

You can also discuss intravenous fluids and feeding methods with your healthcare provider. It is a highly personal choice, but some people choose to continue hydrating and providing nutrients to the body artificially.

Fluids can also be administered subcutaneously—just under the skin—​to maintain a level of hydration and comfort based on your body’s needs and output. Usually, under hospice supervision, some people with malignant obstructions choose to continue eating and drinking a modified diet for comfort measures.

5 SourcesVerywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Franke AJ, Iqbal A, Starr JS, Nair RM, George TJ.Management of Malignant Bowel Obstruction Associated With GI Cancers. J Oncol Pract. 2017;13(7):426-434. doi:10.1200/JOP.2017.022210Chen JH, Huang TC, Chang PY, et al.Malignant bowel obstruction: A retrospective clinical analysis.Mol Clin Oncol. 2014;2(1):13-18. doi:10.3892/mco.2013.216Tuca A, Guell E, Martinez-losada E, Codorniu N.Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution.Cancer Manag Res. 2012;4:159-69. doi:10.2147/CMAR.S29297Mobily M, Patel JA.Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications.World J Gastrointest Endosc.2015;7(4):364-9. doi:10.4253/wjge.v7.i4.364Bozzetti F.The role of parenteral nutrition in patients with malignant bowel obstruction.Support Care Cancer. 2019;27(12):4393-4399. doi:10.1007/s00520-019-04948-1Additional ReadingNational Cancer Institute. (n.d.). Self Study Module 3e: Bowel Obstruction.

5 Sources

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Franke AJ, Iqbal A, Starr JS, Nair RM, George TJ.Management of Malignant Bowel Obstruction Associated With GI Cancers. J Oncol Pract. 2017;13(7):426-434. doi:10.1200/JOP.2017.022210Chen JH, Huang TC, Chang PY, et al.Malignant bowel obstruction: A retrospective clinical analysis.Mol Clin Oncol. 2014;2(1):13-18. doi:10.3892/mco.2013.216Tuca A, Guell E, Martinez-losada E, Codorniu N.Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution.Cancer Manag Res. 2012;4:159-69. doi:10.2147/CMAR.S29297Mobily M, Patel JA.Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications.World J Gastrointest Endosc.2015;7(4):364-9. doi:10.4253/wjge.v7.i4.364Bozzetti F.The role of parenteral nutrition in patients with malignant bowel obstruction.Support Care Cancer. 2019;27(12):4393-4399. doi:10.1007/s00520-019-04948-1Additional ReadingNational Cancer Institute. (n.d.). Self Study Module 3e: Bowel Obstruction.

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

Franke AJ, Iqbal A, Starr JS, Nair RM, George TJ.Management of Malignant Bowel Obstruction Associated With GI Cancers. J Oncol Pract. 2017;13(7):426-434. doi:10.1200/JOP.2017.022210Chen JH, Huang TC, Chang PY, et al.Malignant bowel obstruction: A retrospective clinical analysis.Mol Clin Oncol. 2014;2(1):13-18. doi:10.3892/mco.2013.216Tuca A, Guell E, Martinez-losada E, Codorniu N.Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution.Cancer Manag Res. 2012;4:159-69. doi:10.2147/CMAR.S29297Mobily M, Patel JA.Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications.World J Gastrointest Endosc.2015;7(4):364-9. doi:10.4253/wjge.v7.i4.364Bozzetti F.The role of parenteral nutrition in patients with malignant bowel obstruction.Support Care Cancer. 2019;27(12):4393-4399. doi:10.1007/s00520-019-04948-1

Franke AJ, Iqbal A, Starr JS, Nair RM, George TJ.Management of Malignant Bowel Obstruction Associated With GI Cancers. J Oncol Pract. 2017;13(7):426-434. doi:10.1200/JOP.2017.022210

Chen JH, Huang TC, Chang PY, et al.Malignant bowel obstruction: A retrospective clinical analysis.Mol Clin Oncol. 2014;2(1):13-18. doi:10.3892/mco.2013.216

Tuca A, Guell E, Martinez-losada E, Codorniu N.Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution.Cancer Manag Res. 2012;4:159-69. doi:10.2147/CMAR.S29297

Mobily M, Patel JA.Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications.World J Gastrointest Endosc.2015;7(4):364-9. doi:10.4253/wjge.v7.i4.364

Bozzetti F.The role of parenteral nutrition in patients with malignant bowel obstruction.Support Care Cancer. 2019;27(12):4393-4399. doi:10.1007/s00520-019-04948-1

National Cancer Institute. (n.d.). Self Study Module 3e: Bowel Obstruction.

Meet Our Medical Expert Board

Share Feedback

Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit

Was this page helpful?

Thanks for your feedback!

What is your feedback?OtherHelpfulReport an ErrorSubmit

What is your feedback?